All Eyes on Swvl, Gogoro Gets Approval.

by | Mar 31, 2022

Shared mobility player Swvl (SWVL) makes its debut. PPGH approves its merger with battery-swapping tech provider Gogoro. Deal making isn’t easy as 3 SPACs get extensions. And the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

All eyes on Swvl (SWVL)

Mass transit and shared mobility provider Swvl (SWVL) had its debut today after deSPAC from women-led Queen’s Gambit Growth Capital (GMBT). Swvl is the first company launched from Africa and the second Middle Eastern company to list on the NASDAQ via SPAC merger. Abu Dhabi-based music streaming platform Anghami (ANGH) was the first (last February). SWVL shares closed at $9.90.

PPGH approves merger with Gogoro

Poema Global Holdings Corp. (PPGH) approved its merger with Taiwanese battery swapping provider Gogoro. The transaction, which officially closes on April 4, 2022 , is expected to generate at least $335M in cash for the company. Gogoro will trade on the NASDAQ as “GGR” on April 5, 2022.

Elsewhere in SPACs

Extension for LNFA

L&F Acquisition Corp. (LNFA) filed for an extension from May out to August. No vote date as of yet. The SPAC has a pending deal with cybersecurity provider ZeroFox.

Extension for MPAC

Model Performance Acquisition Corp. (MPAC) will use first of 2 extension options and add $0.10 trust to extend from April to July. The SPAC has a pending deal with Hong-Kong-based animation and gaming company MultiMetaVerse.

Extension for THCA

The extension trend continues, as Tuscan Holdings Corp. II (THCA) gets an extension to June. Low float alert: only 2.7M public shares are remaining: 17.25M at IPO, 2.5M redeemed in April 2021, 2.3M in September 2021, 3.1M in December and 6.65M now. SPAC has ~$10.30 in trust. Originally a cannabis-focussed SPAC, THCA seems to have shifted its focus to real estate, although no DA has been announced. It’s also one of the rare pre-DA SPACs trading above $10 ($11 currently). Recall that the SPAC was rumored to be looking at a deal with freight startup Transfix back in late 2020.

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

Recent Analysis

Daily SPAC Update – December 2, 2024

BACQ, RDAC, CCIR Start Separate Trading. BREZ, JWSM, MNTN Shareholders Approve Extensions. ROCL Deal Approved. AITR + American Metals Deal Terminated.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.